What is the issue size of Suraksha Diagnostic Ltd IPO?

The issue size of the Suraksha Diagnostic Ltd IPO is 8462500000.00.

What is 'pre-apply' for Suraksha Diagnostic Ltd IPO?

Pre-apply will allow you to apply for the Suraksha Diagnostic Ltd IPO 2 days before the subscription period starts.

If I pre-apply for Suraksha Diagnostic Ltd IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Suraksha Diagnostic Ltd IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Suraksha Diagnostic Ltd IPO order is placed?

We will notify you when your Suraksha Diagnostic Ltd IPO order is placed with the exchange.

What are the open and close dates of the Suraksha Diagnostic Ltd IPO?

Suraksha Diagnostic Ltd IPO will be open between 29 Nov '24 and 03 Dec '24.

What is the lot size and minimum order quantity of the Suraksha Diagnostic Ltd IPO?

Suraksha Diagnostic Ltd IPO lot size is 34 and minimum order quantity is 476.

What is the allotment date for the Suraksha Diagnostic Ltd IPO?

Suraksha Diagnostic Ltd IPO allotment date is 04 Dec '24. For Suraksha Diagnostic Ltd IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Suraksha Diagnostic Ltd IPO?

For Suraksha Diagnostic Ltd, the IPO registrar is KARVY. You can check Suraksha Diagnostic Ltd IPO allotment status on the website of the registrar.

Where is the Suraksha Diagnostic Ltd IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.

Suraksha Diagnostic IPO

Suraksha Diagnostic Ltd

₹14,280 /34 sharesMinimum Investment

Suraksha Diagnostic IPO DetailsBidding DatesMin. InvestmentLot SizePrice Range
29 Nov ‘24 - 3 Dec ‘24₹14,28034₹420 - ₹441
Issue SizeIPO Doc
846.25CrRHP PDF
About Suraksha Diagnostic
Suraksha Diagnostic is a diagnostic chain headquartered in Kolkata. The company provides services such as pathology and radiology testing and medical consultation.
Suraksha Diagnostic’s offerings cover routine pathology tests like basic biochemistry and hematology, besides advanced tests such as molecular pathology, histopathology, and specialised biochemistry. Radiology services include basic tests like X-rays and ultrasonography (USG), intermediate and advanced imaging, such as computerised tomography (CT) scans, specialised CT scans, and magnetic resonance imaging (MRI). Apart from this, it provides online and offline consultations. Its polyclinics have doctors across specialities and superspecialities, including cardiology, paediatrics, dermatology, rheumatology, oncology, and nephrology. Suraksha Diagnostic also provides vaccination services with test packages designed for disease prediction and early detection. 
;Founded in
2005
Managing director
Dr. Somnath Chatterjee and Ms.  Ritu Mittal
Parent organisation
Suraksha Diagnostic Ltd
Strengths & Financials of Suraksha DiagnosticStrengths
Risks
Suraksha Diagnostic operates an extensive network comprising a flagship central reference laboratory, eight satellite laboratories (located within diagnostic centres), and 194 customer touchpoints, including 48 diagnostic centres and 146 sample collection centres (primarily franchised), across West Bengal, Bihar, Assam, and Meghalaya as of March 31, 2024.
Three of its laboratories are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), and two advanced diagnostic centres hold accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH).
As of March 31, 2024, 43 diagnostic centres include 120 polyclinic chambers that host over 750 specialised doctors, providing patients with access to expert medical care.
The company offers a comprehensive portfolio of over 2,300 diagnostic tests across various specialities and disciplines. These services are available alongside omnichannel medical consultations, both online and offline, at 43 diagnostic centres equipped with 120 polyclinic chambers.
Suraksha Diagnostic employs a cluster-based 'hub-and-spoke' model. The company claims that this has helped them enhance cost efficiency, standardise testing procedures, and implement deeper brand penetration, especially in remote areas. 
Suraksha Diagnostic is accredited by the College of American Pathologists (CAP) and is ISO-certified. The internationally recognised CAP accreditation helps laboratories meet the standards required for ISO 15189 certification, which is tailored for medical laboratories.
Suraksha Diagnostic Financials
*All values are in Rs. Cr
No Graph Data To Display
Application Details of Suraksha Diagnostic IPOApply asPrice bandApply upto
Regular₹420 - 441₹2 Lakh
High Networth Individual₹420 - 441₹2 - 5 Lakh
For Suraksha Diagnostic IPO, eligible investors can apply as Regular.

Bidding Dates	Min. Investment	Lot Size	Price Range
29 Nov ‘24 - 3 Dec ‘24	₹14,280	34	₹420 - ₹441

Issue Size	IPO Doc
846.25Cr	RHP PDF

Apply as	Price band	Apply upto
Regular	₹420 - 441	₹2 Lakh
High Networth Individual	₹420 - 441	₹2 - 5 Lakh

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

ABOUT GROWW

Groww is India’s No.1 Stock Broker and Trading Platform with more than 1 crore active customers where users can find their investment solutions pertaining to mutual funds, stocks, US Stocks, ETFs, IPO, and F&Os, to invest their money without hassles.

Groww objectively evaluates stocks and mutual funds and does not advise or recommend any stocks, mutual funds or portfolios. Investors shall invest at their own discretion, will and consent. Groww, at any time, does not guarantee fixed returns on the capital invested.

Groww helps investors -

· By providing 100% paperless online free Demat and trading account opening

· By providing an objective evaluation of products available on the platform

· By being transparent about fees and charges involved while investing in a product

· By offering decision-making assistance by providing technical analysis with advanced charts, well-designed line & candlestick charts that indicate share price movements, and market indices, along with more details about all registered and listed companies

SECURE TRANSACTIONS ON GROWW

All transactions on Groww are safe and secure. Users can invest through SIP or Lumpsum using Netbanking through all supported banks. It uses BSE Star MF (with Member code 11724) as transaction platform.

TRADE AND INVEST SECURELY WITH GROWW

Stocks, Mutual fund investments, F&Os, etc., are very popular with individual investors because of their numerous benefits. On Groww, an investor can -

- Invest in Nifty 50 (NSE) & Sensex (BSE) listed stocks

- Diversify across multiple stocks and other instruments

- Start SIP with any amount (as low as Rs. 500)

- Switch regular funds to direct funds

- Start automated monthly investments (SIP), and benefit from many more features

All type of mutual funds are available on Groww.

INVESTING IN MUTUAL FUND PORTFOLIOS

Portfolio is collection of mutual funds designed to meet your investment goals. Investing in mutual fund portfolios helps you in diversifying your investments and reduces the risk. Portfolios also help you in assigning an investment goals and make it easy for you to save for and achieve your goals. You can create a portfolio yourself or ask an expert to build it for you.

ATTENTION INVESTORS

1. For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.

2. For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.

3. KYC is a one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

4. If you are subscribing to an IPO, there is no need to issue a cheque. Please write the Bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non allotment the funds will remain in your bank account.

· Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

· Awareness regarding guidelines on Margin collection

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Issued in the interest of Investors

DISCLAIMER

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, Depository Participant of CDSL Depository with SEBI Registration no: IN-DP-417-2019 and Mutual Fund distributor with AMFI Registration No: ARN-111686. Registered office and Correspondence office - No.11, 2nd floor, 80 FT Road, 4th Block, S.T Bed, Koramangala, Bengaluru – 560034. For any grievances related to Stock Broking/DP, please write to [email protected] , please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Groww Invest Tech Pvt. Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Unless otherwise specified, all returns, expense ratio, NAV, etc are historical and for illustrative purposes only. Future will vary greatly and depends on personal and market circumstances. The information provided by our blog is educational only and is not investment or tax advice.

Mutual fund investments are subject to market risks. Please read all scheme related documents carefully before investing. Past performance of the schemes is neither an indicator nor a guarantee of future performance.

Terms and conditions of the website/app are applicable. Privacy policy of the website is applicable.